Judith Strymish
@JudithStrymish
Followers
324
Following
1K
Media
10
Statuses
415
ID Physician VA Boston, Mom, pretend athlete
West Roxbury, Boston
Joined March 2012
For us ID doctors, the CDC has been a rock. Data, guidelines, surveillance, travel advice -- all there, vetted by experts, referenced, reliable. Perfect? No. But watching its dismantling now breaks my heart. Some thoughts:
blogs.jwatch.org
Throughout my career as an infectious diseases doctor, the CDC has been a rock-solid source. Need reliable data on an outbreak? The CDC. Need thoughtful, evidence-based guidelines? The CDC. Need an...
10
38
139
Implementation of Diagnostic Stewardship to Improve Urinary Tract Infection Antibiotic Use Across Three Medical Centers ✅ Just Accepted https://t.co/7uE5O49C9q
academic.oup.com
AbstractBackground. Overdiagnosis of urinary tract infections (UTIs) and unnecessary antibiotics are common. This is particularly true in older adult popul
0
18
38
In @CIDJournal, @ClaeysKcclaeys and colleagues examined interventions for urine culture ordering, processing, and reporting across three diverse Veterans Affairs (VA) hospitals and evaluated the interventions’ impact on antimicrobial use.
academic.oup.com
AbstractBackground. Overdiagnosis of urinary tract infections (UTIs) and unnecessary antibiotics are common. This is particularly true in older adult popul
0
5
7
In this study that included 42067 adults in 🇺🇸, long-acting lipoglycopeptides (laLGPs) were effective as step-down treatment of serious gram +ve bacterial infections, offering comparable outcomes (readmission/ED visit/90d inpatient☠️) vs SOC antibiotics https://t.co/Dd0ZE6qAk4
0
6
18
Does anyone know why bezlo was discontinued? Seems no reason given? @mmPharmD
🚨News Alert 🚨 💥 Bezlotoxumab (Zinplava) to be discontinued by Merck effective Jan 31 (monoclonal antibody for secondary prevention of C Difficile Infection). @Khanna_S
@pfmets @DrStollman @tony_breu
@gonzalobearman @AmCollegeGastro @IDSAFoundation
https://t.co/NdRmzeyLlu
1
1
0
Rates of post procedural prophylactic antibiotic use following cardiac implantable electronic device insertion and … https://t.co/RSLTmGdZSX 🫀 Good news: declining rate of use. Bad news: use in 40% of patients. Keflex chaser most commonly used. @MayoClinicINFD @MayoClinicCV
pubmed.ncbi.nlm.nih.gov
The use of prophylactic antibiotics following CIED implantation does not correlate to a reduced rate of complex surgical site infection or reduced mortality. The widespread use of these antibiotics,...
0
2
3
Executive Summary: State-of-the-Art Review: Evaluation and Management of Pelvic Osteomyelitis in Stage IV Pressure Injuries: A Multidisciplinary Collaborative Approach https://t.co/DKGDTQfNJt
academic.oup.com
Abstract. Managing pelvic osteomyelitis (POM) in the setting of stage IV pressure injuries requires multidisciplinary evaluation as well as patient and car
1
41
77
In 2 weeks! 😍
✏️ Please mark your calendar 📆🗓️ 🌱🌸2024 MIDS SPRING MEETING You can register 🌐 and we will have a great time 🎙️ 1) recognizing Kass/Finland fellow awardees 2) celebrating Kaplan awardee 3) learning about wastewater-based epidemiology! https://t.co/rigwdoaNOU
0
2
3
Viewpoint discusses the @US_FDA’s authorization of marketing an at-home testing system for chlamydia and gonorrhea as a good first step in boosting access to screening and treatment and in reducing infection rates.
3
2
1
🔥DOTS🔥 The most anticipated RCT #ESCMIDGLOBAL2024 Dalbavancin is non-inferior to SOC by clinical efficacy for complicated SAB incl Rt sided IE 2 doses Dalba 1500 mg on days 1 & 8 or 4-8 wks of SOC(cefaz or naf:MSSA;vanc or dapto:MRSA) DOOR at D70 Slides shared by @LordAlirezaF
6
63
193
Lets talk about Antibiotic PK. This week's 🧵: Distribution! This is where the drug goes after it's absorbed/injected. Where it goes = what target sites it can be used at. Main drug factors: Hydrophilic vs Lipophilic, plasma protein binding, and peripheral tissue binding 1/9
2
74
247
Hospitals testing for C diff using “flipped algorithm” of PCR -> toxin appear “better” in public reporting with less risk of financial penalty. BUT, these hospitals only publicly report 37% of patients who received treatment for C diff.
cambridge.org
Potential underreporting of treated patients using a Clostridioides difficile testing algorithm that screens with a nucleic acid amplification test - Volume 45 Issue 5
2
1
10
🌟🔥 JUST PUBLISHED 🔥🌟 Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by @IDSAInfo and @ASMicrobiology #IDXposts
0
3
15
Is the practice of preoperative urine culture associated with 🔽 risk of postoperative UTI or SSI? Hopefully,the results of this 🆕️🔥study can change the potentially harmful practice of urine testing & antibiotic use in asymptomatic pts prior to surgery! https://t.co/VPMrKQ1ppM
2
19
78
Asymptomatic Testing of Hospital Admissions for SARS-CoV-2: Is it OK to Stop? 🆓 Freely Available https://t.co/OCPkbUfUjp
academic.oup.com
Universal SARS-CoV-2 testing of all persons admitted to acute care hospitals became common practice during the coronavirus disease 2019 (COVID-19) pandemic
0
10
29
Impact of SARS-CoV-2 Arrival Surveillance Screening by Nucleic Acid Amplification Versus Rapid Antigen Detection on Subsequent COVID-19 Infections in Military Trainees 🆓 Freely Available https://t.co/Z3TgoVULUq
academic.oup.com
The efficacy of arrival severe acute respiratory syndrome coronavirus 2 surveillance screening to prevent case clusters of coronavirus disease 2019 among t
0
4
11
MRSA Bacteremia: Vanco alone ✅️ most of the time Combination : Vanco + Rifampin ❌️ Vanco+ Genta ❌️ Vanco + ASP ❌️ Exebacase + Vanco/ Dapto❌️ NeXt ? SNAP Vanco+ Cefazolin ⁉️ We need to rethink our approach! #IDXposts
14
98
278
How good is a negative MRSA nasal swab for ruling out MRSA infection at various sites? NPV for infection in the: ✅Bloodstream: 96.5% ✅Abdomen: 98.6% ✅Respiratory tract: 96.1% ✅Wounds: 93.1% ✅Urinary tract: 99.2% Pretty dang good! https://t.co/lvudAQIZWD
pubmed.ncbi.nlm.nih.gov
Given the high NPVs, MRSA nares screening may be a powerful stewardship tool for deescalation and avoidance of empirical anti-MRSA therapy.
4
40
165
🆕️✨️Single center retrospective study @OFIDJournal Comparative Effectiveness of Fidaxomicin compared to Vancomycin in Populations with Immunocompromising Conditions for the Treatment of Clostridioides difficile Infection #idxposts #MedEd
https://t.co/QtWGjon5EU
1
26
103